Wegovy vs Saxenda: Which GLP-1 Medication Works Better for Weight Loss?

Maria had been on Saxenda for four months when she asked her doctor a straightforward question: "Why am I only down 12 pounds when my friend lost 35 pounds on Wegovy in the same amount of time?" It's a conversation we're having more often in clinical practice, and the answer lies in the fundamental differences between these two GLP-1 receptor agonists. While both medications belong to the same drug class and work through similar mechanisms, the results they deliver are remarkably different.

The data tells a clear story. In head-to-head comparisons, patients taking semaglutide (Wegovy) lost significantly more weight than those taking liraglutide (Saxenda). But weight loss percentages don't tell the whole story about which medication might be right for you. Cost, convenience, side effects, and individual response all play crucial roles in this decision.

How Wegovy and Saxenda Actually Work in Your Body

Both Wegovy and Saxenda are GLP-1 receptor agonists, which means they mimic a hormone your gut naturally produces after eating. This hormone does several important things: it tells your brain you're full, slows down how quickly food leaves your stomach, and helps regulate blood sugar levels. The key difference? Semaglutide (Wegovy) and liraglutide (Saxenda) are different molecules that your body processes very differently.

Wegovy has what we call a longer half-life. That's medical speak for how long a drug stays active in your system. Semaglutide sticks around for about a week, which is why you only need to inject it once weekly. Liraglutide, on the other hand, gets cleared from your body much faster, requiring daily injections to maintain therapeutic levels.

This isn't just about convenience. The longer a GLP-1 medication stays in your system, the more consistent its appetite-suppressing effects. We see this reflected in patient experiences. Those on Wegovy typically report steady appetite control throughout the week, while some Saxenda users notice their hunger increases as they approach their next daily dose.

The molecular structure also affects how strongly each medication binds to GLP-1 receptors. Semaglutide was engineered to bind more tightly and last longer than earlier GLP-1 medications like liraglutide. Think of it as an upgraded version of the same basic technology. This stronger, longer-lasting receptor activation translates directly into the weight loss differences we see in clinical trials.

Both medications also slow gastric emptying, which is why some people experience nausea, especially when starting treatment. Your stomach literally holds onto food longer, which contributes to feeling fuller for extended periods. This effect tends to be more pronounced with Wegovy due to its higher receptor activity, which partly explains why nausea rates are slightly higher compared to Saxenda.

The Weight Loss Results: What Clinical Trials Actually Show

Let's talk numbers, because this is where the comparison gets really interesting. The STEP 1 trial, which examined Wegovy for weight loss, showed that participants lost an average of 14.9% of their body weight over 68 weeks. For a 250-pound person, that's about 37 pounds. Meanwhile, the SCALE Obesity and Prediabetes trial found that Saxenda users lost an average of 8% of their body weight over 56 weeks. For that same 250-pound person, we're looking at about 20 pounds.

That's nearly double the weight loss with Wegovy compared to Saxenda. But averages only tell part of the story.

In the STEP 1 trial, 69% of people taking Wegovy lost at least 10% of their body weight, and 50% lost at least 15%. Those are clinically significant numbers that typically result in meaningful improvements in metabolic health markers like blood pressure, cholesterol, and blood sugar. With Saxenda, about 33.1% of participants achieved at least 10% weight loss, and only 14.4% reached the 15% threshold.

What we see in clinical practice often mirrors these trial results. Patients who switch from Saxenda to Wegovy frequently experience accelerated weight loss, even if they'd hit a plateau on the older medication. However, it's worth noting that any medication producing 5-10% weight loss is considered clinically effective. Saxenda absolutely works. Wegovy just works better for most people.

There's also the question of weight maintenance. The SELECT trial, while primarily designed to study cardiovascular outcomes, showed that people maintained significant weight loss on semaglutide over multiple years. We have less long-term data on Saxenda, though studies suggest that continued use is necessary to maintain weight loss with both medications. Stop either drug, and weight typically returns.

Individual variation matters too. Some people respond exceptionally well to Saxenda and may not need the stronger effects of Wegovy. Others experience minimal results with Saxenda but excellent results with semaglutide. Genetic factors, lifestyle habits, and metabolic differences all influence how your body responds to these medications.

Dosing Schedules, Injections, and Daily Convenience

Here's where lifestyle considerations become crucial. Wegovy requires one injection per week, while Saxenda demands a daily commitment. That might not sound like a huge difference on paper, but it absolutely affects adherence and quality of life.

The Saxenda injection schedule means you're thinking about your medication every single day. You need to keep it refrigerated, remember to take it at roughly the same time daily, and manage your supply carefully when traveling. Miss a dose, and you might notice increased hunger the next day. For some people, this daily ritual serves as a helpful reminder of their weight loss commitment. For others, it becomes tedious.

Wegovy's weekly schedule offers more flexibility. Pick a day that works for you, set a reminder, and you're done for the week. Traveling is easier since you're packing fewer pens. The consistent medication levels throughout the week also mean more predictable appetite control without the subtle peaks and troughs that can occur with daily dosing.

Both medications use pre-filled injection pens that are relatively simple to use. The needles are small, typically 32-gauge, and most patients report that injections are much less painful than they anticipated. You'll inject into subcutaneous fat in your abdomen, thigh, or upper arm. The actual injection takes just seconds.

Saxenda comes in a multi-dose pen that requires you to dial up your prescribed dose each day, starting at 0.6 mg and potentially increasing to 3.0 mg. Wegovy uses single-dose pens at various strengths (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg), which you'll progress through over several months. Each pen is used once and discarded.

In our clinical experience, adherence rates tend to be higher with weekly medications compared to daily ones. Life gets busy. People forget doses. When that medication is supposed to be taken daily, missed doses add up quickly and can compromise results. Weekly dosing simply has fewer opportunities for non-adherence.

Side Effects: What to Expect and How They Compare

The side effect profiles of Wegovy and Saxenda are quite similar since they work through the same mechanism. Gastrointestinal issues top the list for both medications. Nausea, constipation, diarrhea, and occasional vomiting are the most common complaints, especially during the initial weeks and when increasing doses.

Wegovy tends to produce slightly higher rates of nausea, likely because of its stronger GLP-1 receptor activation and slower gastric emptying. In the STEP trials, about 44% of participants reported nausea at some point, compared to about 39% in the Saxenda SCALE trials. However, most people find that nausea improves significantly after the first few weeks as their body adjusts.

Both medications can cause what patients often describe as "GLP-1 fatigue" during the adjustment period. You might feel more tired than usual, especially in the first month. This typically resolves as your body adapts to the medication and your new eating patterns stabilize.

Injection site reactions occur with both drugs but are generally mild—maybe some redness or slight swelling that resolves within a day or two. Rotating injection sites and letting the medication come to room temperature before injecting can minimize these reactions.

There are rare but serious side effects that apply to both medications. These include pancreatitis, gallbladder problems, and potential thyroid tumors (seen in rodent studies but not confirmed in humans). Both medications carry a black box warning about thyroid C-cell tumors and shouldn't be used if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

What we tell our patients: the gastrointestinal side effects are generally manageable with a few strategies. Eat smaller portions, avoid high-fat meals that sit heavily in your stomach, stay well-hydrated, and don't rush dose increases if you're struggling with side effects. Most people find that the side effects are tolerable given the weight loss results they're achieving.

What Women Should Know

Women represented the majority of participants in both the STEP and SCALE trials, and the medications proved effective across diverse female populations. However, there are some gender-specific considerations worth discussing.

If you're of childbearing age, both Wegovy and Saxenda require careful contraception planning. You should discontinue these medications at least two months before trying to conceive, as we don't have adequate safety data on GLP-1 use during pregnancy. Neither medication is recommended while breastfeeding either.

Many women notice that these medications help break the cycle of emotional and hormonal eating. The appetite suppression isn't just physical—it seems to quiet food noise and reduce cravings, which can be particularly helpful during certain phases of your menstrual cycle when cravings typically intensify. Some women report that their relationship with food fundamentally changes on these medications.

Women with PCOS may see additional benefits beyond weight loss. Both medications can improve insulin sensitivity, which often helps regulate menstrual cycles and may improve fertility. However, this improved fertility means contraception becomes even more important if you're not planning a pregnancy.

What Men Should Know

Men typically lose weight faster than women on both Wegovy and Saxenda, largely due to higher baseline muscle mass and metabolic rates. In clinical trials, men often reached their weight loss goals a few weeks earlier than female participants, though the percentage of body weight lost was similar.

One concern we sometimes hear from male patients: will GLP-1 medications affect muscle mass? The research shows that weight lost on these medications is primarily fat, not muscle, especially when combined with resistance training. However, you'll want to prioritize protein intake (aim for at least 100-120 grams daily) and maintain a strength training routine to preserve muscle as you lose weight.

Some men experience improved testosterone levels as they lose weight on these medications, since excess body fat—particularly visceral fat—can suppress testosterone production. This can lead to improved energy, mood, and libido as treatment progresses.

Men should also be aware that these medications can affect how alcohol hits you. With slower gastric emptying and reduced food intake, alcohol may feel stronger and potentially cause more pronounced side effects. Moderate your alcohol consumption accordingly, especially when you're adjusting to the medication.

From the Ozari Care Team

We've seen hundreds of patients navigate the choice between these medications, and here's what we typically recommend: if you're choosing between brand-name Wegovy and Saxenda based purely on effectiveness, Wegovy's clinical data is stronger. However, cost often becomes the deciding factor, and that's where compounded semaglutide changes the equation entirely. At Ozari, we provide compounded semaglutide at a fraction of the brand-name cost, making the more effective medication actually more accessible. We also find that patients appreciate having a care team they can message with questions about side effects, dosing, and progress—weight loss isn't just about the medication, it's about having support throughout your journey.

Key Takeaways

• Wegovy (semaglutide) produces nearly twice the average weight loss compared to Saxenda (liraglutide)—14.9% versus 8% in clinical trials—making it the more effective option for most people seeking significant weight loss.
• Wegovy requires only one injection per week while Saxenda needs daily injections, which significantly affects convenience and adherence over time.
• Both medications have similar side effect profiles dominated by gastrointestinal issues like nausea and constipation, though these typically improve after the first few weeks of treatment.
• Cost is often the deciding factor between these medications, but compounded semaglutide offers the effectiveness of Wegovy at a price point that's often more affordable than brand-name Saxenda.
• Individual response varies—while the average results favor Wegovy, some patients respond well to Saxenda and may not need the stronger medication, making personalized medical guidance essential.

Frequently Asked Questions

Can I switch from Saxenda to Wegovy if I'm not losing enough weight?

Yes, switching from Saxenda to Wegovy is common and generally straightforward. Many patients make this transition when they hit a plateau on liraglutide or want more significant weight loss. Your healthcare provider will typically have you stop Saxenda and start Wegovy at its lowest dose (0.25 mg weekly) to minimize side effects, even though you've already been on a GLP-1 medication. Some people experience renewed nausea when switching, but it's usually milder than what first-time users experience since your body has some GLP-1 tolerance built up.

Is Wegovy really worth the extra cost compared to Saxenda?

Brand-name Wegovy typically costs $1,300-$1,600 per month without insurance, while Saxenda runs about $1,400-$1,500 monthly—they're actually quite similar in price at the pharmacy. However, compounded semaglutide changes this calculation dramatically, often costing $99-$300 monthly depending on your dose and provider. Given that Wegovy produces nearly double the weight loss of Saxenda in clinical trials and requires fewer injections, most patients find the more effective medication worth pursuing, especially when compounded versions make it more affordable than brand-name Saxenda.

How long does it take to see results with each medication?

Most people notice reduced appetite within the first week or two on either medication, but significant weight loss takes longer. With Saxenda, you might see 5-10 pounds lost in the first month, while Wegovy users often report 8-15 pounds in that same timeframe, though individual results vary widely. The most dramatic results typically occur between months three and six as you reach higher maintenance doses. Remember that both medications involve gradual dose escalation over several weeks, so you're not at full therapeutic strength immediately—patience during the initial titration period is important.

What happens if I miss a dose of Wegovy or Saxenda?

For Saxenda's daily dosing, if you miss a dose, just take your next scheduled dose—don't double up. If you've missed multiple days, contact your healthcare provider as you may need to restart at a lower dose to avoid severe nausea. With Wegovy's weekly schedule, if you're within five days of your missed dose, take it as soon as you remember, then resume your regular schedule. If it's been more than five days, skip that dose and take your next one on the regularly scheduled day. Missing occasional doses with either medication will reduce effectiveness but won't cause harm.

Do I need to take these medications forever to keep the weight off?

Current evidence suggests that these medications work best as long-term treatments rather than short-term fixes. Studies show that most people regain a significant portion of lost weight within a year of stopping either Wegovy or Saxenda. Think of it similarly to how blood pressure or cholesterol medications work—they're effective while you're taking them, but the underlying condition doesn't disappear. Some patients successfully transition to a lower maintenance dose after reaching their goal weight, while others find they need to continue at their full dose. The decision about duration should be made collaboratively with your healthcare provider based on your individual response, goals, and how well you're maintaining lifestyle changes.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, shipped to your door. Learn more at ozarihealth.com.